Gyre Therapeutics, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Jun 2017 | — | -5,355.0% | -5,294.6% |
| Sep 2017 | — | -1,848.4% | -1,821.7% |
| Mar 2018 | — | -111,316.7% | -84,033.3% |
| Mar 2020 | — | -31.0% | -24.8% |
| Jun 2020 | — | -1,047.1% | -1,040.3% |
| Sep 2020 | — | -1,802.9% | -1,795.4% |
| Mar 2021 | — | -1,529.5% | -1,529.5% |
| Jun 2021 | — | -1,759.2% | -1,760.4% |
| Sep 2021 | — | -1,097.4% | -1,097.8% |
| Mar 2022 | — | -1,851.5% | -1,830.7% |
| Mar 2023 | 95.5% | 26.7% | 16.9% |
| Jun 2023 | 96.3% | 17.0% | 12.9% |
| Sep 2023 | 96.3% | 39.8% | 23.4% |
| Mar 2024 | 96.4% | 29.7% | 36.6% |
| Jun 2024 | 96.9% | 12.7% | 18.0% |
| Sep 2024 | 96.2% | 16.6% | 11.2% |
| Mar 2025 | 95.9% | 10.3% | 22.4% |
| Jun 2025 | 86.2% | -7.5% | -7.5% |
| Sep 2025 | 94.7% | 22.7% | 19.4% |
| Mar 2026 | 94.6% | -41.5% | -82.5% |
| Jun 2026 | 92.4% | -49.3% | -49.0% |